144 ·Filed May 4, 2026

CELC

Celcuity Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001000275-26-000043
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine pre-planned sale by a director under a 10b5-1 plan. No immediate trading signal. Monitor for any actual Form 4 filings to confirm execution, but no action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CELC ▼ -42.57% at T+60d
NEUTRAL call ✗ call lost -42.57% · α vs SPY -44.43% · entry $144.98 → $83.26
Entry anchored
May 4, 02:17 PM ET
via exchange tick
T+1d
-2.27%
call -2.27% · α -3.06%
$141.69
settled 5mo ago
T+5d
-13.34%
call -13.34% · α -16.28%
$125.64
settled 5mo ago
T+20d
-15.19%
call -15.19% · α -20.83%
$122.96
settled 4mo ago
T+60d
-42.57%
call -42.57% · α -44.43%
$83.26
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Director David Dalvey filed a Form 144 notice of intent to sell 25,000 shares of Celcuity Inc. common stock, with an approximate market value of $3,517,000 based on the filing date. The sale is planned under a Rule 10b5-1 trading plan established on August 19, 2025, indicating a pre-planned, non-discretionary transaction. Given the director role (not CEO/CFO), the pre-planned nature, and the relatively small proportion relative to the company's $6.1B market cap, this filing is routine and carries no material signal.

Key Facts

  • Insider: David Dalvey, Director
  • Shares to be sold: 25,000 shares of common stock
  • Approximate market value: $3,517,000
  • Sale intended under Rule 10b5-1 plan established on August 19, 2025
  • Filing date: May 4, 2026
  • Broker: RBC Capital Markets LLC

Financial Impact

Proposed sale of 25,000 shares worth approximately $3.5 million, representing a small fraction of the company's $6.1B market cap.

dilution

Risk Factors

  • Insider selling could be misinterpreted by the market as a negative signal, though the 10b5-1 plan mitigates this.
  • No material risk to the company from this transaction.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
88% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001000275-26-000043
Document: 0001000275-26-000043-index.html0001000275-26-000043
Document: 0001000275-26-000043.txt0001000275-26-000043
15 reports for CELC
Performance horizon
89% Hit rate 8 of 9 directional calls best @ T+20▲ +26.84%Jun 11, 2026
Filters
Rows
Reports for CELC — sortable, filterable
TypeNow
Aug 26, 2026
5w ago
8-K
BULLISH ★ 7/10
$95.08 $84.00▼ −11.65%▼ −12.86%$72.51 (−23.74%)
Jul 15, 2026
11w ago
144
BEARISH ★ 6/10
$91.51 $92.08▼ −0.62%▲ +1.72%$72.51 (+20.76%)
Jul 14, 2026
11w ago
Press Release
BULLISH ★ 8/10
$91.51 $92.08▲ +0.62%▼ −1.72%$72.51 (−20.76%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 5/10
$89.49 $113.51▲ +26.84%▲ +24.95%$72.51 (−18.97%)
Jun 8, 2026
16w ago
8-K
MIXED ★ 6/10
$92.59 $115.72▲ +24.98%▲ +23.53%$72.51 (−21.69%)
Jun 5, 2026
17w ago
424B5
MIXED ★ 6/10
$88.28 $108.58▲ +23.00%▲ +21.13%$72.51 (−17.86%)
Jun 4, 2026
17w ago
Press Release
MIXED ★ 6/10
$92.47 $107.95▲ +16.74%▲ +18.11%$72.51 (−21.59%)
Jun 3, 2026
17w ago
Press Release
BEARISH ★ 6/10
$88.95 $107.95▼ −21.36%▼ −22.36%$72.51 (+18.48%)
Jun 3, 2026
17w ago
424B5
BEARISH ★ 6/10
$88.95 $107.95▼ −21.36%▼ −22.36%$72.51 (+18.48%)
Jun 2, 2026
17w ago
8-K
BULLISH ★ 8/10
$91.42 $104.49▲ +14.30%▲ +15.86%$72.51 (−20.68%)
Showing 10 of 15

US Market Status

Market Open — Closes in 2h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access